Estazolam
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gloria Picoy [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Estazolam is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Estazolam FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Estazolam in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Estazolam in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Estazolam FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Estazolam in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Estazolam in pediatric patients.
Contraindications
There is limited information regarding Estazolam Contraindications in the drug label.
Warnings
There is limited information regarding Estazolam Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Estazolam Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Estazolam Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Estazolam Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Estazolam in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Estazolam in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Estazolam during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Estazolam in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Estazolam in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Estazolam in geriatric settings.
Gender
There is no FDA guidance on the use of Estazolam with respect to specific gender populations.
Race
There is no FDA guidance on the use of Estazolam with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Estazolam in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Estazolam in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Estazolam in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Estazolam in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Estazolam Administration in the drug label.
Monitoring
There is limited information regarding Estazolam Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Estazolam and IV administrations.
Overdosage
There is limited information regarding Estazolam overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Estazolam Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Estazolam Mechanism of Action in the drug label.
Structure
There is limited information regarding Estazolam Structure in the drug label.
Pharmacodynamics
There is limited information regarding Estazolam Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Estazolam Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Estazolam Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Estazolam Clinical Studies in the drug label.
How Supplied
There is limited information regarding Estazolam How Supplied in the drug label.
Storage
There is limited information regarding Estazolam Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Estazolam |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Estazolam |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Estazolam Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Estazolam interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Estazolam Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Estazolam Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
File:Estazolam.svg | |
File:Estazolam3d.png | |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 93% |
Metabolism | Hepatic |
Elimination half-life | 10-24 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H11ClN4 |
Molar mass | 294.7 |
Estazolam (marketed under the brand names ProSom, Eurodin) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Estazolam is an intermediate-acting oral benzodiazepine.
It is commonly prescribed for short-term treatment of insomnia.
Pharmacology
Estazolam is classed as a "triazolo" benzodiazepine drug.[1] An animal study demonstrated that estazolam induces a drowsy pattern of spontaneous EEG including high voltage slow waves and spindle bursts increase in the cortex and amygdala, while the hippocampal theta rhythm is desynchronized. Also low voltage fast waves occur particularly in the cortical EEG. The EEG arousal response to auditory stimulation and to electric stimulation of the mesencephalic reticular formation, posterior hypothalamus and centromedian thalamus is significantly suppressed. The photic driving response elicited by a flash light in the visual cortex is significantly suppressed by estazolam.[2] Estazolam at high doses decreases histamine turnover via it's action at the benzodiazepine-GABA receptor complex.[3]
Estazolam and other benzodiazepines may influence neurosteroid metabolism which in turn may influence the functions of the brain and reproductive system. The pharmacological actions of benzodiazepines at the GABAa receptor are similar to those of neurosteroids. Neuroactive steroids are positive allosteric modulators of the GABAa receptor, enhancing GABA function. Many hypnotic benzodiazepines (nimetazepam, temazepam, estazolam, flunitrazepam and nitrazepam) potently inhibit the enzymes involved in the metabolism of neurosteroids. Long-term administration of benzodiazepines may influence the concentrations of endogenous neurosteroids, and thereby would modulate the emotional state. Factors which effects benzodiazepines ability to alter neurosteroid levels depend on the molecular make up of the individual benzodiazepine. Presence of a substituent at N1 position of the diazepine ring and/or the chloro or nitro group at position 7 of the benzene ring contribute to potent inhibition of the isoenzymes, and in turn a bromo group at position 7 (for bromazepam) and additional substituents (3-hydroxy group for oxazepam and tetrahydroxazole ring for cloxazolam and oxazolam) decrease the inhibitory potency.[4]
Abuse
Estazolam became notorious in 1998 when a large amount of a 'herbal sleeping mix' called Sleeping Buddha was recalled from the shelves after the FDA descovered that it contained estazolam (as well as some heavy metal salts).[citation needed]
See also
References
- ↑ Braestrup C (1978). "Pharmacological characterization of benzodiazepine receptors in the brain". Eur J Pharmacol. 48 (3): 263–70. PMID 639854. Unknown parameter
|day=
ignored (help); Unknown parameter|coauthors=
ignored (help); Unknown parameter|month=
ignored (help) - ↑ Watanabe S (1986). "[Electroencephalographic effects of 450191-S and its metabolites in rabbits with chronic electrode implants]". Nippon Yakurigaku Zasshi. 88 (1): 19–32. PMID 3758874. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help) - ↑ Oishi R (27). "Diazepam-induced decrease in histamine turnover in mouse brain". Eur J Pharmacol. 124 (3): 337–42. PMID 3089825. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help); Check date values in:|date=, |year= / |date= mismatch
(help) - ↑ Usami N (2002). "Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines" (pdf). Biol Pharm Bull. 25 (4): 441–5. PMID 11995921. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help)
External links
- Pages with script errors
- Pages with citations using unsupported parameters
- CS1 errors: dates
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from November 2007
- Articles with invalid date parameter in template
- Benzodiazepines
- Hypnotics
- Triazoles